• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cross-sectional study of population-specific streptococcal antibody titres in Uganda.乌干达特定人群链球菌抗体滴度的横断面研究。
Arch Dis Child. 2020 Sep;105(9):825-829. doi: 10.1136/archdischild-2020-318859. Epub 2020 Jun 29.
2
Normal ranges of streptococcal antibody titers are similar whether streptococci are endemic to the setting or not.无论链球菌在该环境中是否为地方病,链球菌抗体滴度的正常范围都是相似的。
Clin Vaccine Immunol. 2009 Feb;16(2):172-5. doi: 10.1128/CVI.00291-08. Epub 2008 Dec 3.
3
Revising the value of Antistreptolysin O titre in childhood and its interpretation in the diagnostic approach of rheumatic diseases.修订抗链球菌溶血素 O 效价在儿童中的价值及其在风湿性疾病诊断中的应用。
Eur J Pediatr. 2024 Feb;183(2):835-842. doi: 10.1007/s00431-023-05269-6. Epub 2023 Dec 1.
4
New normal ranges of antistreptolysin O and antideoxyribonuclease B titres for Australian children.澳大利亚儿童抗链球菌溶血素O和抗脱氧核糖核酸酶B滴度的新正常范围。
J Paediatr Child Health. 2005 Nov;41(11):583-6. doi: 10.1111/j.1440-1754.2005.00726.x.
5
Antistreptolysin O and antideoxyribonuclease B titres in blood donors and in patients with features of nonsuppurative sequelae of group A streptococcus infection in Tanzania.坦桑尼亚献血者及具有A组链球菌感染非化脓性后遗症特征患者的抗链球菌溶血素O和抗脱氧核糖核酸酶B滴度
East Afr Med J. 1995 Jan;72(1):33-6.
6
The sensitivity and specificity of an agglutination test for antibodies to streptococcal extracellular antigens: a quantitative analysis and comparison of the Streptozyme test with the anti-streptolysin O and anti-deoxyribonuclease B tests.链球菌细胞外抗原抗体凝集试验的敏感性和特异性:对链激酶试验与抗链球菌溶血素O及抗脱氧核糖核酸酶B试验的定量分析与比较
J Pediatr. 1980 Mar;96(3 Pt 1):367-73. doi: 10.1016/s0022-3476(80)80674-3.
7
Comparative study of antistreptolysin O, antideoxyribonuclease B and multienzyme tests in streptococcal infections.抗链球菌溶血素O、抗脱氧核糖核酸酶B及多种酶检测在链球菌感染中的比较研究
Health Lab Sci. 1977 Oct;14(4):284-90.
8
Streptococcal antibodies among rural school children in Bangladesh.孟加拉国农村学童中的链球菌抗体
Bangladesh Med Res Counc Bull. 2002 Apr;28(1):1-6.
9
Asymptomatic infection by Streptococcus pyogenes in schoolchildren and diagnostic usefulness of antideoxyribonuclease B.小学生中化脓性链球菌的无症状感染及抗脱氧核糖核酸酶B的诊断价值
J Korean Med Sci. 2005 Dec;20(6):938-40. doi: 10.3346/jkms.2005.20.6.938.
10
Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset.近期发作的发作性睡病患者抗链球菌抗体升高。
Sleep. 2009 Aug;32(8):979-83. doi: 10.1093/sleep/32.8.979.

引用本文的文献

1
Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting.高负担环境下儿童早期血清学特征及对化脓性链球菌天然保护性体液免疫的发展
Nat Med. 2025 Aug 8. doi: 10.1038/s41591-025-03868-4.
2
Streptococcal Serology Reference Intervals in an Australian Pediatric Cohort.澳大利亚儿科队列中的链球菌血清学参考区间
J Pediatric Infect Dis Soc. 2025 Aug 7;14(7). doi: 10.1093/jpids/piaf054.
3
Determination of the upper limit of normal for serum anti-streptolysin-O titre in primary school children in Southern Nigeria; A model for other low resource settings.尼日利亚南部小学生血清抗链球菌溶血素O滴度正常上限的测定;其他资源匮乏地区的一个范例
Int J Cardiol Cardiovasc Risk Prev. 2024 Mar 25;21:200256. doi: 10.1016/j.ijcrp.2024.200256. eCollection 2024 Jun.
4
Revising the value of Antistreptolysin O titre in childhood and its interpretation in the diagnostic approach of rheumatic diseases.修订抗链球菌溶血素 O 效价在儿童中的价值及其在风湿性疾病诊断中的应用。
Eur J Pediatr. 2024 Feb;183(2):835-842. doi: 10.1007/s00431-023-05269-6. Epub 2023 Dec 1.
5
Correlates of immunity to Group A Streptococcus: a pathway to vaccine development.A组链球菌免疫相关性:疫苗研发之路
NPJ Vaccines. 2023 Jan 17;8(1):1. doi: 10.1038/s41541-022-00593-8.
6
Standardization of Epidemiological Surveillance of Acute Rheumatic Fever.急性风湿热流行病学监测的标准化
Open Forum Infect Dis. 2022 Sep 15;9(Suppl 1):S41-S49. doi: 10.1093/ofid/ofac252. eCollection 2022 Sep.
7
Study of streptococcal antibody (anti-streptolysin O) among healthy children in Bangladesh.孟加拉国健康儿童的链球菌抗体(抗链球菌溶血素O)研究。
SAGE Open Med. 2022 Jun 28;10:20503121221108558. doi: 10.1177/20503121221108558. eCollection 2022.
8
Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum.风湿热和风湿性心脏病连续体的最新进展
Pathogens. 2022 Jan 28;11(2):179. doi: 10.3390/pathogens11020179.
9
Normal values of antistreptolysin O for adults ages 30 to 70 in Syria: A cross sectional study.叙利亚30至70岁成年人抗链球菌溶血素O的正常参考值:一项横断面研究。
Ann Med Surg (Lond). 2021 Nov 5;71:103015. doi: 10.1016/j.amsu.2021.103015. eCollection 2021 Nov.
10
Incidence of acute rheumatic fever in northern and western Uganda: a prospective, population-based study.乌干达北部和西部急性风湿热的发病率:一项前瞻性、基于人群的研究。
Lancet Glob Health. 2021 Oct;9(10):e1423-e1430. doi: 10.1016/S2214-109X(21)00288-6. Epub 2021 Aug 19.

本文引用的文献

1
Prevalence of group A β-hemolytic streptococcal throat carriage and prospective pilot surveillance of streptococcal sore throat in Ugandan school children.A 组β-溶血性链球菌咽部携带率的流行情况和乌干达学龄儿童链球菌性咽痛的前瞻性试点监测。
Int J Infect Dis. 2020 Apr;93:245-251. doi: 10.1016/j.ijid.2020.01.013. Epub 2020 Jan 20.
2
Streptococcal Serology in Acute Rheumatic Fever Patients: Findings From 2 High-income, High-burden Settings.链球菌血清学在急性风湿热患者中的应用:来自 2 个高收入、高负担国家的研究结果。
Pediatr Infect Dis J. 2019 Jan;38(1):e1-e6. doi: 10.1097/INF.0000000000002190.
3
The novel Group A Streptococcus antigen SpnA combined with bead-based immunoassay technology improves streptococcal serology for the diagnosis of acute rheumatic fever.基于珠粒的免疫分析技术与新型 A 组链球菌抗原 SpnA 联合应用提高了链球菌血清学在急性风湿热诊断中的应用。
J Infect. 2018 Apr;76(4):361-368. doi: 10.1016/j.jinf.2017.12.008. Epub 2017 Dec 18.
4
Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci.儿童咽峡部 A 组链球菌感染后免疫应答的前瞻性纵向分析。
J Pediatric Infect Dis Soc. 2017 Jun 1;6(2):187-196. doi: 10.1093/jpids/piw070.
5
Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation.乌干达的风湿性心脏病:就诊一年后发病和死亡的预测因素
BMC Cardiovasc Disord. 2017 Jan 7;17(1):20. doi: 10.1186/s12872-016-0451-8.
6
Detection of upper limit of normal values of anti-DNase B antibody in children's age groups who were admitted to hospital with noninfectious reasons.对因非感染性原因入院的儿童年龄组抗DNase B抗体正常上限值的检测。
North Clin Istanb. 2015 Sep 23;2(2):136-141. doi: 10.14744/nci.2015.39358. eCollection 2015.
7
Handheld echocardiographic screening for rheumatic heart disease by non-experts.非专业人员使用手持式超声心动图筛查风湿性心脏病
Heart. 2016 Jan;102(1):35-9. doi: 10.1136/heartjnl-2015-308236. Epub 2015 Oct 5.
8
Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association.超声心动图检查时代急性风湿热琼斯诊断标准修订:美国心脏协会的科学声明。
Circulation. 2015 May 19;131(20):1806-18. doi: 10.1161/CIR.0000000000000205. Epub 2015 Apr 23.
9
The utility of handheld echocardiography for early rheumatic heart disease diagnosis: a field study.手持式超声心动图在早期风湿性心脏病诊断中的应用:一项现场研究。
Eur Heart J Cardiovasc Imaging. 2015 May;16(5):475-82. doi: 10.1093/ehjci/jeu296. Epub 2015 Jan 5.
10
ASO titer or not? When to use streptococcal serology: a guide for clinicians.是否检测抗链球菌溶血素O滴度?何时使用链球菌血清学检查:临床医生指南
Eur J Clin Microbiol Infect Dis. 2015 May;34(5):845-9. doi: 10.1007/s10096-014-2303-8. Epub 2015 Jan 6.

乌干达特定人群链球菌抗体滴度的横断面研究。

Cross-sectional study of population-specific streptococcal antibody titres in Uganda.

机构信息

Uganda Heart Institute Ltd, Kampala, Uganda.

Children's National Health System, Washington, District of Columbia, USA.

出版信息

Arch Dis Child. 2020 Sep;105(9):825-829. doi: 10.1136/archdischild-2020-318859. Epub 2020 Jun 29.

DOI:10.1136/archdischild-2020-318859
PMID:32601082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11149943/
Abstract

OBJECTIVE

Despite substantial variation of streptococcal antibody titres among global populations, there is no data on normal values in sub-Saharan Africa. The objective of this study was to establish normal values for antistreptolysin O (ASO) and antideoxyribonuclease B (ADB) antibodies in Uganda.

DESIGN

This was an observational cross-sectional study.

SETTING

This study was conducted at Mulago National Referral Hospital, which is located in the capital city, Kampala, and includes the Uganda Heart Institute.

PATIENTS

Participants (aged 0-50 years) were recruited. Of 428 participants, 22 were excluded from analysis, and 183 (44.4%) of the remaining were children aged 5-15 years.

MAIN OUTCOME MEASURES

ASO was measured in-country by nephelometric technique. ADB samples were sent to Australia (PathWest) for analysis by enzyme inhibition assay: 80% upper limit values were established.

RESULTS

The median ASO titre in this age group was 220 IU/mL, with the 80th percentile value of 389 IU/mL. The median ADB titre in this age group was 375 IU/mL, with the 80th percentile value of 568 IU/mL.

CONCLUSIONS

The estimated Ugandan paediatric population standardised 80% upper-limit-of-normal ASO and ADB titres is higher than many global populations. Appropriateness of using population-specific antibody cutoffs is yet to be determined and has important implications for the sensitivity and specificity of rheumatic fever diagnosis.

摘要

目的

尽管全球人群的链球菌抗体滴度存在很大差异,但在撒哈拉以南非洲地区尚无关于正常值的数据。本研究旨在确定乌干达人群抗链球菌溶血素 O(ASO)和脱氧核糖核酸酶 B(ADB)抗体的正常值。

设计

这是一项观察性横断面研究。

地点

本研究在位于首都坎帕拉的穆拉戈国家转诊医院进行,该医院包括乌干达心脏研究所。

患者

招募了年龄在 0-50 岁之间的参与者。在 428 名参与者中,有 22 名被排除在分析之外,其余的 183 名(44.4%)是 5-15 岁的儿童。

主要观察指标

采用散射比浊法在国内检测 ASO。ADB 样本被送到澳大利亚(PathWest)进行酶抑制分析:确定 80%上限值。

结果

该年龄组的 ASO 中位数为 220IU/mL,第 80 百分位值为 389IU/mL。该年龄组的 ADB 中位数为 375IU/mL,第 80 百分位值为 568IU/mL。

结论

估计乌干达儿科人群的标准化 80%上限正常 ASO 和 ADB 滴度高于许多全球人群。使用人群特异性抗体切点的适当性尚未确定,这对风湿热诊断的敏感性和特异性有重要影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a2/11149943/360517af6398/nihms-1994061-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a2/11149943/07d74d01408a/nihms-1994061-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a2/11149943/360517af6398/nihms-1994061-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a2/11149943/07d74d01408a/nihms-1994061-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2a2/11149943/360517af6398/nihms-1994061-f0002.jpg